Lymphosarcoma terminating in acute myelogenous leukemia.
D000328:Adult; D003036:Cobalt Isotopes; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000209:etiology*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D011867:Radioisotope Teletherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D014499:Uracil Mustard / Q000009:adverse effects / Q000627:therapeutic use
D003036:Cobalt Isotopes; D003520:Cyclophosphamide; D014499:Uracil Mustard; D003630:Daunorubicin